Annual FCF
-$38.94 M
-$19.99 M-105.46%
31 December 2023
Summary:
Verrica Pharmaceuticals annual free cash flow is currently -$38.94 million, with the most recent change of -$19.99 million (-105.46%) on 31 December 2023. During the last 3 years, it has fallen by -$7.26 million (-22.93%). VRCA annual FCF is now -2317.07% below its all-time high of -$1.61 million, reached on 31 December 2016.VRCA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$8.57 M
+$7.79 M+47.62%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly free cash flow is currently -$8.57 million, with the most recent change of +$7.79 million (+47.62%) on 30 September 2024. Over the past year, it has increased by +$6.30 million (+42.36%). VRCA quarterly FCF is now -489.20% below its all-time high of $2.20 million, reached on 30 June 2021.VRCA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$59.62 M
+$6.30 M+9.56%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM free cash flow is currently -$59.62 million, with the most recent change of +$6.30 million (+9.56%) on 30 September 2024. Over the past year, it has dropped by -$30.40 million (-104.02%). VRCA TTM FCF is now -11613.95% below its all-time high of -$509.00 thousand, reached on 31 March 2017.VRCA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -105.5% | +42.4% | -104.0% |
| 3 y3 years | -22.9% | +19.4% | -127.8% |
| 5 y5 years | -108.8% | -8.4% | -117.4% |
VRCA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -105.5% | at low | -590.5% | +57.0% | -373.2% | +9.6% |
| 5 y | 5 years | -108.8% | at low | -489.2% | +57.0% | -373.2% | +9.6% |
| alltime | all time | -2317.1% | at low | -489.2% | +57.0% | <-9999.0% | +9.6% |
Verrica Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.57 M(-47.6%) | -$59.62 M(-9.6%) |
| June 2024 | - | -$16.37 M(-17.9%) | -$65.93 M(+21.4%) |
| Mar 2024 | - | -$19.95 M(+35.4%) | -$54.28 M(+39.4%) |
| Dec 2023 | -$38.94 M(+105.5%) | -$14.73 M(-1.0%) | -$38.94 M(+33.2%) |
| Sept 2023 | - | -$14.88 M(+214.6%) | -$29.23 M(+131.9%) |
| June 2023 | - | -$4.73 M(+2.8%) | -$12.60 M(-17.1%) |
| Mar 2023 | - | -$4.60 M(-8.3%) | -$15.21 M(-19.8%) |
| Dec 2022 | -$18.95 M(-33.4%) | -$5.02 M(-387.2%) | -$18.95 M(-17.1%) |
| Sept 2022 | - | $1.75 M(-123.8%) | -$22.87 M(-35.1%) |
| June 2022 | - | -$7.33 M(-12.1%) | -$35.25 M(+37.1%) |
| Mar 2022 | - | -$8.35 M(-6.6%) | -$25.71 M(-9.7%) |
| Dec 2021 | -$28.46 M(-10.1%) | -$8.94 M(-16.0%) | -$28.46 M(+8.8%) |
| Sept 2021 | - | -$10.64 M(-582.8%) | -$26.17 M(+12.5%) |
| June 2021 | - | $2.20 M(-119.9%) | -$23.25 M(-31.9%) |
| Mar 2021 | - | -$11.10 M(+67.0%) | -$34.17 M(+7.9%) |
| Dec 2020 | -$31.68 M | -$6.64 M(-13.9%) | -$31.68 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$7.72 M(-11.4%) | -$33.25 M(-0.6%) |
| June 2020 | - | -$8.71 M(+1.2%) | -$33.44 M(+12.3%) |
| Mar 2020 | - | -$8.61 M(+4.7%) | -$29.78 M(+6.0%) |
| Dec 2019 | -$28.09 M(+50.6%) | -$8.22 M(+3.9%) | -$28.09 M(+2.4%) |
| Sept 2019 | - | -$7.91 M(+56.6%) | -$27.43 M(+11.2%) |
| June 2019 | - | -$5.05 M(-27.0%) | -$24.67 M(+5.5%) |
| Mar 2019 | - | -$6.92 M(-8.4%) | -$23.39 M(+25.5%) |
| Dec 2018 | -$18.65 M(+306.9%) | -$7.55 M(+46.7%) | -$18.65 M(+44.1%) |
| Sept 2018 | - | -$5.15 M(+36.5%) | -$12.94 M(+46.0%) |
| June 2018 | - | -$3.77 M(+73.8%) | -$8.87 M(+42.0%) |
| Mar 2018 | - | -$2.17 M(+17.5%) | -$6.25 M(+36.3%) |
| Dec 2017 | -$4.58 M(+184.5%) | -$1.85 M(+71.8%) | -$4.58 M(+67.5%) |
| Sept 2017 | - | -$1.07 M(-6.7%) | -$2.74 M(+64.7%) |
| June 2017 | - | -$1.15 M(+126.3%) | -$1.66 M(+226.3%) |
| Mar 2017 | - | -$509.00 K | -$509.00 K |
| Dec 2016 | -$1.61 M | - | - |
FAQ
- What is Verrica Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual FCF year-on-year change?
- What is Verrica Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly FCF year-on-year change?
- What is Verrica Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM FCF year-on-year change?
What is Verrica Pharmaceuticals annual free cash flow?
The current annual FCF of VRCA is -$38.94 M
What is the all time high annual FCF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual free cash flow is -$1.61 M
What is Verrica Pharmaceuticals annual FCF year-on-year change?
Over the past year, VRCA annual free cash flow has changed by -$19.99 M (-105.46%)
What is Verrica Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of VRCA is -$8.57 M
What is the all time high quarterly FCF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly free cash flow is $2.20 M
What is Verrica Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, VRCA quarterly free cash flow has changed by +$6.30 M (+42.36%)
What is Verrica Pharmaceuticals TTM free cash flow?
The current TTM FCF of VRCA is -$59.62 M
What is the all time high TTM FCF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM free cash flow is -$509.00 K
What is Verrica Pharmaceuticals TTM FCF year-on-year change?
Over the past year, VRCA TTM free cash flow has changed by -$30.40 M (-104.02%)